Why the study?
Does a preemptive strategy of hemodynamic monitoring and coupled therapy reduce surgical mortality and morbidity in moderate and high-risk surgical patients?
Does a preemptive strategy of hemodynamic monitoring and coupled therapy reduce surgical mortality and morbidity in moderate and high-risk surgical patients?
Preemptive hemodynamic monitoring and coupled therapy reduces surgical mortality and morbidity in moderate and high-risk surgical patients.
Supports adoption of preemptive hemodynamic monitoring in moderate- and high-risk surgery; strengthens Level 1 evidence for outcome improvement.
The use of a preemptive strategy of hemodynamic monitoring and coupled therapy reduces surgical mortality and morbidity.
No takes yet. Share an insight, caveat, or question.
Hamilton et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: